Current Medicines | Medicines | Eli Lilly and Company
WEBFor more than 145 years, we have worked tirelessly to develop and deliver trusted medicines and diagnostics that meet real needs. Our growing portfolio of medicines includes treatments in the areas of bone muscle joint, cancer, cardiovascular, diabetes, endocrine, immunology, neuroscience and obesity. The product information on this website is ...
A Medicine Company | Eli Lilly and Company
WEBLearn the latest information on the availability of Lilly diabetes and obesity medicines. Learn how to protect yourself from counterfeit Mounjaro ® and Zepbound ® and unapproved tirzepatide products.
Diabetes Medications and Support Programs | Eli ... - Eli Lilly and Company
WEBFor more than 90 years, Lilly has been committed to diabetes and meeting the needs of people affected by diabetes with treatment options, support programs and more.
FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and ...
WEBINDIANAPOLIS, Sept. 13, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to …
Available Medications - Lilly Cares
WEBIf your medication is not listed or you don't meet the Lilly Cares eligibility requirements, please refer to the. You are encouraged to report negative side effects of prescription drugs to the FDA. Access the full list of available medications from Lilly Cares.
FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight ...
WEBNov 8, 2023 · Lilly is putting a commercial savings card program in place that will help people who may benefit from Zepbound better access it. People who are commercially insured with coverage for Zepbound may be eligible to pay as low as $25 for a 1-month or 3-month prescription.
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug ... - CNN
WEBJun 11, 2024 · On Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lilly’s drug donanemab, a monoclonal antibody designed to slow the progression of...
What is Lilly Cares | Lilly Cares
WEBLilly Cares Foundation, Inc. (Lilly Cares) is a nonprofit charitable organization that provides prescribed Lilly medications for up to 12 months for free to qualifying U.S. patients. Helping patients with significant financial need receive their prescribed Lilly medications at …
Trulicity (dulaglutide) - LillyMedical - Eli Lilly and Company
WEBTrulicity is a once-weekly injectable prescription medicine to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It should be used along with diet and exercise.
FDA Approves Lilly and Incyte's OLUMIANT ... - Eli Lilly and …
WEBINDIANAPOLIS, June 13, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has approved OLUMIANT ® (baricitinib), a once-daily pill, as a first-in-disease systemic treatment for adults with severe alopecia …
Skip to content